Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials

OBJECTIVE: The influence of dipeptidyl peptidase-4 (DPP4) inhibitors on glycemic variability compared to other oral antidiabetic drugs (OADs), measured based on the mean amplitude of glycemic excursions (MAGE), has not been comprehensively analyzed. The aim of the study was to perform a meta-analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Shangyu, Zhang, Ruya, Zhang, Ye, Carr, Richard David, Zheng, Yiman, Rajpathak, Swapnil, Yu, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396280/
https://www.ncbi.nlm.nih.gov/pubmed/36017316
http://dx.doi.org/10.3389/fendo.2022.935039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396280/
https://www.ncbi.nlm.nih.gov/pubmed/36017316
http://dx.doi.org/10.3389/fendo.2022.935039

Ejemplares similares